The groundbreaking treatment of the medication represents a major development in the care of the condition. Distinct from existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide965947.blogsvila.com/42350379/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment